Results 311 to 320 of about 3,019,224 (363)
RNA liquid biopsy via nanopore sequencing for novel biomarker discovery and cancer early detection
Peddu V +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Liquid biopsy enters the clinic — implementation issues and future challenges
Nature Reviews Clinical Oncology, 2021Michail Ignatiadis +2 more
exaly +2 more sources
The future of liquid biopsy [PDF]
The Lancet Oncology, 2020 The analysis of tumours using biomarkers in blood is beginning to transform cancer diagnosis, says Catherine Alix-Panabieres. The challenge now is to make liquid biopsy a standard clinical tool. The analysis of tumours using biomarkers in blood is beginning to transform cancer diagnosis, says Catherine Alix-Panabieres.
Jane Ganeshalingam +2 more
openaire +4 more sources
2023
تم تطوير طرق جديدة للنظر في جينات الورم وديناميكياته: الخزعة السائلة (LB)، والتي تم دمجها في الممارسة السريرية كتحليل غير جراحي للمواد المتداولة المستمدة من الأورام، والتي تمثل أداة مبتكرة في علم الأورام الدقيق وتتغلب على القيود الحالية المرتبطة بخزعات الأنسجة. LB هي أداة جديدة ذات قيمة كبيرة، وتشكل علامة تشخيصية وتنبؤية وتنبؤية.
Alejandra Avagnina, María José Serrano
openaire +1 more source
تم تطوير طرق جديدة للنظر في جينات الورم وديناميكياته: الخزعة السائلة (LB)، والتي تم دمجها في الممارسة السريرية كتحليل غير جراحي للمواد المتداولة المستمدة من الأورام، والتي تمثل أداة مبتكرة في علم الأورام الدقيق وتتغلب على القيود الحالية المرتبطة بخزعات الأنسجة. LB هي أداة جديدة ذات قيمة كبيرة، وتشكل علامة تشخيصية وتنبؤية وتنبؤية.
Alejandra Avagnina, María José Serrano
openaire +1 more source
Genes, Chromosomes and Cancer, 2019
AbstractLiquid biopsy is based on minimally invasive blood tests and has a high potential to significantly change the therapeutic strategy in cancer patients, providing an extremely powerful and reliable noninvasive clinical tool for the individual molecular profiling of patients in real time.
Evi Lianidou, Klaus Pantel
openaire +2 more sources
AbstractLiquid biopsy is based on minimally invasive blood tests and has a high potential to significantly change the therapeutic strategy in cancer patients, providing an extremely powerful and reliable noninvasive clinical tool for the individual molecular profiling of patients in real time.
Evi Lianidou, Klaus Pantel
openaire +2 more sources
The potential of liquid biopsies
Current Opinion in Oncology, 2016This article discusses the current status and applications of liquid biopsy in nonsmall cell lung cancer (NSCLC).The discovery of genetic alterations which are responsible for the development and progression of NSCLC led to the identification of a new generation of molecular biomarkers.
Martin Filipits +2 more
openaire +2 more sources
Liquid biopsy in cancer: current status, challenges and future prospects
Signal Transduction and Targeted TherapyCancer has a high mortality rate across the globe, and tissue biopsy remains the gold standard for tumor diagnosis due to its high level of laboratory standardization, good consistency of results, relatively stable samples, and high accuracy of results ...
Liwei Ma +7 more
semanticscholar +1 more source